Medication info
Glybix 5mg (Memantine Hydrochloride)

Glybix 5mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›5mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202503062 · Approved 2025.11.25

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Administer orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1-7): Administer 5mg once daily for 7 days. Week 2 (Days 8-14): Administer 10mg once daily for 7 days. Week 3 (Days 15-21): Administer 15mg once daily for 7 days. From week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps slow the progression of Alzheimer's disease and improves cognitive function.

How to take

Adult dose

Administer orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (Days 1-7): Administer 5mg once daily for 7 days. Week 2 (Days 8-14): Administer 10mg once daily for 7 days. Week 3 (Days 15-21): Administer 15mg once daily for 7 days. From week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-titration schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients who have an allergic reaction to any of its components. Administration is prohibited for patients with severely impaired liver function or very poor kidney function. Patients with a history of epilepsy or seizures, and those at high risk of developing epilepsy should exercise caution when using this medication. Use with similar acting medications such as Amantadine, Ketamine, or Dextromethorphan may increase central nervous system side effects, and should be avoided. Situations that can alter urine acidity, such as abrupt dietary changes to vegetarianism, excessive intake of alkaline beverages, or certain urinary tract infections, require careful monitoring of urine acidity changes. Safety has not been established in patients with recent myocardial infarction, heart failure, or uncontrolled hypertension, and it should be used with caution in these patients. Side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur; consult a doctor if symptoms are severe. This medication can interact with other drugs, so make sure to inform medical personnel if you are taking NMDA antagonists, antipsychotic medications, muscle relaxants, or anticoagulants. Women who are pregnant or may become pregnant should carefully consider the potential risks to the fetus before using this medication; it is recommended to discontinue breastfeeding if lactating. It is advised not to use this medication in children and adolescents under 18 years of age since safety and efficacy have not been established. In cases of overdose, symptoms such as confusion, drowsiness, dizziness, hallucinations, and seizures may occur, and immediate medical attention is required. Patients taking this medication should be cautious when driving or operating machinery, as reaction times may be slowed; special care should be taken for safety. Lastly, this medication should be kept out of the reach of children, and it is important to avoid transferring it to other containers to maintain the quality of the medication.

Side effects

  • dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 33 more
  • psychiatric reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis
  • thromboembolism
  • dyspnea
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucination
  • gait disturbance
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • delirium
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it should be stored at room temperature between 1 to 30 degrees Celsius. Storing in this manner will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.